close

Thank you

 

Sign up to receive updates from the Gates Foundation

Privacy Policy
Bill & Melinda Gates Foundation
Countries / Austria

Vaccine against Toxic Shock Syndrome successfully tested in a Phase I trial

Researchers from MedUni Vienna, in collaboration with Biomedizinische Forschungsgesellschaft mbH in Vienna, have developed the world's first vaccine against Toxic Shock Syndrome (TSS) and successfully tested it in a Phase I trial.

Full Blog Post

Details

Exciting News for HIV Prevention

As I mentioned in my speech to the XVIII International AIDS Conference on Monday, one promising area in the fight against HIV/AIDS is antiretroviral (ARV)-based prevention: pills, injections, and gels that contain the drugs now used for treatment.

Full Blog Post

Details

Avahan: The Business of HIV Prevention at Scale

When the Avahan team first went to an AIDS conference in Toronto, we were nervous about presenting our model of prevention to the HIV community.

Full Blog Post

Details

Global HIV Prevention Progress Report Card 2010 Released in Vienna

Today the Global HIV Prevention Working Group released the first comprehensive report card on global HIV prevention at the XVIII International AIDS Conference. The Global HIV Prevention Progress Report Card 2010 noted encouraging momentum on HIV prevention, with countries and donors taking steps to strengthen HIV prevention programs. But it was also a bit of a reality check. It warns that global HIV prevention programs aren’t having the full impact they could.

Full Blog Post

Details

Building on Success: A Roadmap for HIV Prevention

I’m honored to speak at the XVIII International AIDS Conference in Vienna today. This conference marks an important turning point in the fight against AIDS.

Full Blog Post

Details